Weiss Lawrence Martin 4
4 · NEOGENOMICS INC · Filed Apr 26, 2021
Insider Transaction Report
Form 4
Weiss Lawrence Martin
Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Stock
2021-04-22$9.22/sh+6,667$61,470→ 112,464 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-04-22−9,005→ 18,012 totalExercise: $19.60Exp: 2024-03-01→ Common Stock (9,005 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2021-04-22−9,378→ 28,136 totalExercise: $28.33Exp: 2027-03-02→ Common Stock (9,378 underlying) - Exercise/Conversion
Common Stock
2021-04-22$19.60/sh+9,005$176,498→ 121,469 total - Exercise/Conversion
Common Stock
2021-04-22$28.33/sh+9,378$265,679→ 130,847 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-04-22−6,667→ 0 totalExercise: $9.22Exp: 2023-04-19→ Common Stock (6,667 underlying)
Holdings
- 8,334
Stock Option (Right to Buy)
Exercise: $13.87Exp: 2023-12-12→ Common Stock (8,334 underlying) - 29,895
Stock Option (Right to Buy)
Exercise: $53.17Exp: 2028-03-02→ Common Stock (29,895 underlying)
Footnotes (5)
- [F1]On April 19, 2018, Dr. Weiss was granted 20,000 stock options. These options vested ratably over the first three anniversary dates of the grant date.
- [F2]On March 1, 2019, Dr. Weiss was granted 36,022 stock options. These options vest ratably over the first four anniversary dates of the grant date.
- [F3]On March 2, 2020, Dr. Weiss was granted 37,514 stock options. These options vest ratably over the first four anniversary dates of the grant date.
- [F4]On December 12, 2018, Dr. Weiss was granted 25,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.
- [F5]On March 2, 2021, Dr. Weiss was granted 29,895 stock options. These options vest ratably over the first four anniversary dates of the grant date.